Acrobiosystems for English
icon_bulk_orderAchat groupé/Commande rapide
user
  1. Tableau de bord
  2. Mon profil
  3. Mon adresse
  4. Mes commandes
  5. Adhésion à Acro
Connexion Inscription
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2 |Cadherin-17 
0
Il n'y a pas de produit dans le panier !
Mon panier|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > APRIL

APRIL

Brief Information

Name:Tumor necrosis factor ligand superfamily member 13
Target Synonym:Tumor Necrosis Factor Ligand 7B,CD256 Antigen,TNLG7B,CD256,TNF- and APOL-related leukocyte expressed ligand 2,TNFSF13,TNF-related death ligand 1,ZTNF2,TALL-2,APRIL,Tumor necrosis factor ligand superfamily member 13,TNF Superfamily Member 13,Tumor Necrosis Factor (Ligand) Superfamily, Member 13,TRDL-1,TALL2,Tumor Necrosis Factor Superfamily Member 13,Tumor Necrosis Factor-Like Protein ZTNF2,UNQ383/PRO715,A Proliferation-Inducing Ligand,Tumor Necrosis Factor-Related Death Ligand-1
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:10
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
APL-H5263 Human Human APRIL / TNFSF13 Protein, Fc Tag, active trimer
APL-H5263-structure
APL-H5263-sds
APL-H82Q8 Human Biotinylated Human APRIL / TNFSF13 Protein, Avitag™,His Tag, active trimer (MALS verified)
APL-H82Q8-sds
APL-C52D2 Cynomolgus Cynomolgus APRIL / TNFSF13 Protein, His,Flag Tag, active trimer (MALS verified)
APL-C52D2-sds
APL-H52D1 Human Human APRIL / TNFSF13 Protein, His,Flag Tag, active trimer (MALS verified)
APL-H52D1-sds
APL-H82F5 Human Biotinylated Human APRIL / TNFSF13 Protein, Fc,Avitag™
APL-H82F5-structure
APL-H82F5-sds
ACRO Quality

Part of Bioactivity data

APL-H52D1-BLI
APRIL BLI

Loaded Human APRIL Protein, His,Flag Tag (Cat. No. APL-H52D1) on HIS1K Biosensor, can bind Human BCMA, Fc Tag (Cat. No. BC7-H5254) with an affinity constant of 1.88 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
APL-H52D1-BLI
APRIL BLI

Loaded Human APRIL Protein, His,Flag Tag (Cat. No. APL-H52D1) on HIS1K Biosensor, can bind Human TACI Protein, Fc Tag with an affinity constant of 75 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol

Synonym Name

APRIL,TNFSF13,TALL-2,TRDL-1,CD256,TALL2,ZTNF2

Background

APRIL(a proliferation-inducing ligand) is also known as Tumor necrosis factor ligand superfamily member 13, TALL-2, TRDL-1, CD256, TNFFSF 13, cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. APRIL is a cytokine of the tumor necrosis factor family associated mainly with hematologic malignancies. The closely related TNF family ligands B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) serve in the generation and maintenance of mature B-lymphocytes. Both BAFF and APRIL assemble as homotrimers that bind and activate several receptors that they partially share. BAFF-APRIL heteromers of different stoichiometries have distinct receptor-binding properties and activities. In addition, expression of APRIL was regulated by miR-145 in GC cells.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Telitacicept RCT-18; RC-18; RCT18; RC18 Approved RemeGen Co Ltd 泰爱 Mainland China Lupus Erythematosus, Systemic RemeGen Co Ltd 2021-03-09 Myasthenia Gravis; Multiple Sclerosis, Relapsing-Remitting; Glomerulonephritis, IGA; Sjogren's Syndrome; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Neuromyelitis Optica; Lupus Erythematosus, Systemic Details
Telitacicept RCT-18; RC-18; RCT18; RC18 Approved RemeGen Co Ltd 泰爱 Mainland China Lupus Erythematosus, Systemic RemeGen Co Ltd 2021-03-09 Myasthenia Gravis; Multiple Sclerosis, Relapsing-Remitting; Glomerulonephritis, IGA; Sjogren's Syndrome; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Neuromyelitis Optica; Lupus Erythematosus, Systemic Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Atacicept TACI-Ig Phase 3 Clinical Zymogenetics Inc Glomerulonephritis, IGA; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Optic Neuritis; Lupus Erythematosus, Systemic Details
Zigakibart BION-1301 Phase 3 Clinical Aduro Biotech Inc Glomerulonephritis, IGA; Proteinuria; Multiple Myeloma Details
Sibeprenlimab VIS-649 Phase 3 Clinical Visterra Inc Glomerulonephritis, IGA; Glomerulonephritis Details
Povetacicept ALPN-303; ALPN 30x Phase 2 Clinical Alpine Immune Sciences Inc Purpura, Thrombocytopenic, Idiopathic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Myasthenia Gravis; Glomerulonephritis, IGA; Sjogren's Syndrome; Lupus Nephritis; Glomerulonephritis, Membranous; Lupus Erythematosus, Systemic; Anemia, Hemolytic, Autoimmune; Inflammation; Cytopenia; Glomerulonephritis Details
Anti-BCMA CAR T-cell therapy (Actavis/Eugia Pharma) Phase 1 Clinical Eugia Pharma Specialities Ltd, Actavis Inc Multiple Myeloma Details
anti-TriPRIL CAR T-cell therapy（Massachusetts General Hospital） Phase 1 Clinical Massachusetts General Hospital Multiple Myeloma Details
AUR-200 AUR-200; AUR200 Phase 1 Clinical Thunderbolt Pharma Inc Autoimmune Diseases Details
RO-7297089 RO-7297089; AFM-26; RG-6296 Phase 1 Clinical Genentech Inc Multiple Myeloma Details
APRIL CAR-T Cell therapy (Yake Biotechnology) Phase 1 Clinical Shanghai YaKe Biotechnology Co Ltd Multiple Myeloma Details
Anti-BCMA CAR T-cell therapy (Huazhong University of Science and Technology) Clinical Huazhong University Of Science And Technology Multiple Myeloma Details
Atacicept TACI-Ig Phase 3 Clinical Zymogenetics Inc Glomerulonephritis, IGA; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Optic Neuritis; Lupus Erythematosus, Systemic Details
Zigakibart BION-1301 Phase 3 Clinical Aduro Biotech Inc Glomerulonephritis, IGA; Proteinuria; Multiple Myeloma Details
Sibeprenlimab VIS-649 Phase 3 Clinical Visterra Inc Glomerulonephritis, IGA; Glomerulonephritis Details
Povetacicept ALPN-303; ALPN 30x Phase 2 Clinical Alpine Immune Sciences Inc Purpura, Thrombocytopenic, Idiopathic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Myasthenia Gravis; Glomerulonephritis, IGA; Sjogren's Syndrome; Lupus Nephritis; Glomerulonephritis, Membranous; Lupus Erythematosus, Systemic; Anemia, Hemolytic, Autoimmune; Inflammation; Cytopenia; Glomerulonephritis Details
Anti-BCMA CAR T-cell therapy (Actavis/Eugia Pharma) Phase 1 Clinical Eugia Pharma Specialities Ltd, Actavis Inc Multiple Myeloma Details
anti-TriPRIL CAR T-cell therapy（Massachusetts General Hospital） Phase 1 Clinical Massachusetts General Hospital Multiple Myeloma Details
AUR-200 AUR-200; AUR200 Phase 1 Clinical Thunderbolt Pharma Inc Autoimmune Diseases Details
RO-7297089 RO-7297089; AFM-26; RG-6296 Phase 1 Clinical Genentech Inc Multiple Myeloma Details
APRIL CAR-T Cell therapy (Yake Biotechnology) Phase 1 Clinical Shanghai YaKe Biotechnology Co Ltd Multiple Myeloma Details
Anti-BCMA CAR T-cell therapy (Huazhong University of Science and Technology) Clinical Huazhong University Of Science And Technology Multiple Myeloma Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Laisser un message

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap